Involvement of activator protein-1 (AP-1) in induction of apoptosis by Vitamin E succinate in human breast cancer cells

Molecular Carcinogenesis

Volumn 19, Issue 3, 1997, Pages 180-190

  Zhao, Bihong ^a,b   Yu, Weiping ^a   Qian, Ming ^a   Simmons Menchaca, Maria ^a   Brown, Powel ^b   Birrer, Michael J ^c   Sanders, Bob G ^a   Kline, Kimberly ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

C jun dominant negative mutant; MCF 7 human breast cancer cells; Programmed cell death; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; DIAGNOSIS; DNA DETERMINATION; DNA SYNTHESIS INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

APOPTOSIS; BLOTTING, NORTHERN; BREAST NEOPLASMS; DNA, NEOPLASM; HUMANS; MUTATION; NEOPLASMS, HORMONE-DEPENDENT; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR CELLS, CULTURED; VITAMIN E;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030751535     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199707)19:3<180::AID-MC6>3.0.CO;2-I     Document Type: Article

References (35)

1. Prasad KN, Edwards-Prasad J. Vitamin E and cancer prevention: Recent advances and future potentials. J Am Coll Nutr 11:487-500, 1992.
2. Kline K, Yu W, Zhao B, et al. Vitamin E succinate: Mechanisms of action as tumor cell growth inhibitor. In: Prasad KN, Santamaria L, Williams RM (eds), Nutrients in Cancer Prevention and Treatment, Humana, Totowa, NJ, 1995, pp. 36-56.
3. Turley JM, Sanders BG, Kline K. RRR-α-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr Cancer 18:201-213, 1992.
4. Charpentier A, Groves S, Simmons-Menchaca M, et al. RRR-α-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells. Nutr Cancer 19:225-239, 1993.
5. Simmons-Menchaca M, Qian M, Yu W, Sanders BG, Kline K. RRR-α-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-β by avian retrovirus-transformed lymphoid cells. Nutr Cancer 24:171-185, 1995.
6. Turley JM, Funakoshi S, Ruscetti FW, et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor β. Cell Growth Differ 6:655-663, 1995.
7. Yu W, Sanders BG, Kline K. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate. Nutr Cancer 25:138-149, 1996.
8. Charpentier A, Simmons-Menchaca M, Yu W, et al. RRR-α-tocopheryl succinate enhances TGF-β1, -β2, and -β3, and TGF-βR-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer 26:237-250, 1996.
9. Qian M, Sanders BG, Kline K. RRR-α-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. Nutr Cancer 25:9-26, 1996.
10. Sporn MB, Roberts AB. Interactions of retinoids and transforming growth factor-beta in regulation of cell differentiation and proliferation. Mol Endocrinol 5:3-7, 1991.
11. Klotz DM, Castles CG, Fuqua SA, Spriggs LL, Hill SM. Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness. Biochem Biophys Res Commun 210:609-615, 1995.
12. Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1413, 1973.
13. Slack R, Proulx P. Studies on the effects of vitamin E on neuro-blastoma NIE 115. Nutr Cancer 12:75-82, 1989.
14. Traber MG, Thellman CA, Rindler MJ, Kayden HJ. Uptake of intact TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate), a water-miscible form of vitamin E, by human cells in vitro. Am J Clin Nutr 48:605-611, 1988.
15. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22:5506-5507, 1994.
16. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982.
17. Curran T, Gordon MB, Rubino KL, Sambucetti LC. Isolation and characterization of the c-fos (rat) cDNA and analysis of posttranslational modification in vitro. Oncogene 2:79-84, 1987.
18. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of protooncogene JUN/AP-1 by serum and TPA. Nature 334:629-631, 1988.
19. Brown PH, Alani R, Preis LH, Szabo E, Birrer MJ. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8:877-886, 1993.
20. Yu W, Sanders BG, Kline K. RRR-α-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DMA synthesis arrest. Nutr Cancer 27:92-101, 1997.
21. Martin SJ, Green DR, Cotter TG. Dicing with death: Dissecting the components of the apoptosis machinery. Trends Biochem Sci 19:26-30, 1994.
22. White E. Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15, 1996.
23. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14:1798-1811, 1995.
24. Pertovaara L, Sistonen L, Bos TJ, Vogt PK, Keski-Oja J, Alitalo K. Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol Cell Biol 9:1255-1262, 1989.
25. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157, 1991.
26. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 49:1266-1272, 1990.
27. Deng T, Karin M. Jun B differs from c-Jun in its DMA-binding and dimerization domains, and represses c-Jun formation of inactive heterodimers. Genes Dev 7:479-490, 1993.
28. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M. Mouse Jun D negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76:747-760, 1994.
29. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720-3724, 1991.
30. Brown PH, Chen TK, Birrer MJ. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791-800, 1994.
31. Collotta F, Polentarutti N, Sironi M, Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cells lines. J Biol Chem 267:18278-18283, 1992.
32. Ham J, Babij C, Whitfield J, et al. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939, 1995.
33. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995.
34. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79, 1996.
35. Chen Y-R, Wang X, Templeton D, Davis RJ, Tan T-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J Biol Chem 271:31929-31936, 1996.